Gwilym Thompson
About Gwilym Thompson
Gwilym Thompson is the Group Director of Worldwide Health Economics and Outcomes Research (Markets - RoW) at Bristol Myers Squibb in London, England, with extensive experience in health economics and outcomes research across various pharmaceutical companies.
Current Role at Bristol Myers Squibb
Gwilym Thompson is currently the Group Director Worldwide Health Economics and Outcomes Research (Markets - RoW) at Bristol Myers Squibb based in London, England, United Kingdom. He has been in this role since March 2020 and is responsible for the Haematology and CAR-T franchises.
Previous Roles at Bristol Myers Squibb
Before his current position, Gwilym Thompson served as the Director Worldwide Health Economics & Outcomes Research, Markets at Bristol Myers Squibb in Uxbridge from 2017 to 2020. This tenure marks his initial years at the company, contributing significantly to strategic health economics and outcomes research.
Experience at The Janssen Pharmaceutical Companies of Johnson & Johnson
Gwilym Thompson held multiple roles at The Janssen Pharmaceutical Companies of Johnson & Johnson. He was the Health Economics Lead from 2015 to 2017 and Health Economics Lead, Diabetes, from 2013 to 2014. Additionally, he served as Associate Director, Health Economics Market Access Reimbursement from 2011 to 2012, all positions based in London, United Kingdom.
Early Career Experience
Gwilym Thompson's career includes a variety of roles in health economics and research. He worked as a Manager, GHO Oncology at GlaxoSmithKline from 2008 to 2010, a Consultant at Bridgehead International from 2004 to 2008, and as a Research Associate at Covance Laboratories from 2001 to 2004. His early career laid a strong foundation in the pharmaceutical and consultancy sectors.
Educational Background
Gwilym Thompson completed his PhD at the University of Leicester from 1997 to 2001. He holds an MSc in Neuroscience from The University of Edinburgh, achieved in 1997, and an MA in Natural Sciences from the University of Cambridge, completed in 1994. He also studied at Woodbridge School from 1984 to 1991.